Journal of neuroimaging : official journal of the American Society of Neuroimaging · 2026
T1w/T2w Ratio Identifies the Basolateral Amygdala as a Preferential Target in Autoimmune Limbic Encephalitis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dadarwal Rakshit, Dik Andre, Bierhansl Laura, Gmahl Noëmi, Landmeyer Nils C, Brix Tobias J, Jaeger Veronika K, Bauer Jochen, Küker Wilhelm, Wiendl Heinz, Elger Christian E, Kovac Stjepana, Bischof Antje
Аннотация
BACKGROUND AND PURPOSE: The amygdala plays a key role in the pathophysiology of autoimmune limbic encephalitis (ALE), contributing to epileptic seizures and neuropsychiatric symptoms. While no study has examined microstructural changes in individual amygdala nuclei in ALE, we used the T1-weighted/T2-weighted (T1w/T2w) ratio to explore amygdalar pathology and its associations with clinical manifestations, including epilepsy and neuropsychiatric symptoms.
METHODS: This single-center study examined 57 patients diagnosed with ALE and 16 healthy controls (HC). Patients underwent a comprehensive assessment that included clinical, electroencephalogram (EEG), magnetic resonance imaging (MRI), and neuropsychological assessments. Patients were stratified by epileptic focus based on long-term EEG. T1w/T2w ratio and volumetric measures of the amygdala and its nuclei were analyzed and correlated with epileptic focus and neuropsychiatric outcomes.
RESULTS: EEG revealed 26 left temporal, 26 bitemporal, and five right temporal epileptic foci. The T1w/T2w ratio in the left amygdala was markedly reduced in patients with left temporal (p = 0.013) and bitemporal (p = 0.018) epileptic foci compared to HC. This reduction was most pronounced in the left basolateral complex (p = 0.011). Whereas amygdalar volumes were similar between patients and HC, exploratory analyses showed an increased volume of the left lateral nucleus in left temporal ALE (p = 0.036). Furthermore, we found no correlations between MRI measures and neuropsychiatric scores.
CONCLUSION: Our findings indicate that the basolateral complex of the amygdala is preferentially affected in ALE, suggesting a region-specific vulnerability to autoimmune-mediated inflammation. T1w/T2w ratio alterations reflect the epileptogenic focus and may serve as a clinically accessible, noninvasive biomarker for early diagnosis and treatment monitoring in ALE.
METHODS: This single-center study examined 57 patients diagnosed with ALE and 16 healthy controls (HC). Patients underwent a comprehensive assessment that included clinical, electroencephalogram (EEG), magnetic resonance imaging (MRI), and neuropsychological assessments. Patients were stratified by epileptic focus based on long-term EEG. T1w/T2w ratio and volumetric measures of the amygdala and its nuclei were analyzed and correlated with epileptic focus and neuropsychiatric outcomes.
RESULTS: EEG revealed 26 left temporal, 26 bitemporal, and five right temporal epileptic foci. The T1w/T2w ratio in the left amygdala was markedly reduced in patients with left temporal (p = 0.013) and bitemporal (p = 0.018) epileptic foci compared to HC. This reduction was most pronounced in the left basolateral complex (p = 0.011). Whereas amygdalar volumes were similar between patients and HC, exploratory analyses showed an increased volume of the left lateral nucleus in left temporal ALE (p = 0.036). Furthermore, we found no correlations between MRI measures and neuropsychiatric scores.
CONCLUSION: Our findings indicate that the basolateral complex of the amygdala is preferentially affected in ALE, suggesting a region-specific vulnerability to autoimmune-mediated inflammation. T1w/T2w ratio alterations reflect the epileptogenic focus and may serve as a clinically accessible, noninvasive biomarker for early diagnosis and treatment monitoring in ALE.